Rhythm's experimental drug to treat a form of obesity meets main goal in study-March 2024-www.financetom.com

Rhythm's experimental drug to treat a form of obesity meets main goal in study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Rhythm's experimental drug to treat a form of obesity meets main goal in study

Jul 9, 2025 5:22 AM

July 9 (Reuters) - Rhythm Pharmaceuticals ( RYTM ) said

on Wednesday that its experimental drug to treat a type of

obesity met the main goal in a mid-stage study.

Previous page： Exclusive-China's state importer books US soy purchases as tariff threat looms Next page： Cansortium Completes RIV Capital Acquisition, Adding New York Retail, Wholesale, Cannabis Cultivation Operations

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Exclusive-China's state importer books US soy purchases as tariff threat looms

Dec 19, 2024

CHICAGO (Reuters) - China's Sinograin has bought nearly 500,000 metric tons of U.S. soybeans this week for shipment in March and April, paying more for U.S. supplies for state reserves rather than buying cheaper Brazilian beans, two U.S. traders familiar with the deals said. China is the world's top soy buyer and a crucial market for both U.S. and Brazilian...

Cansortium Completes RIV Capital Acquisition, Adding New York Retail, Wholesale, Cannabis Cultivation Operations

Dec 19, 2024

Cansortium Inc ( CNTMF ). (CSE:TIUM) also known as FLUENT and RIV Capital Inc ( CNPOF ). (CSE:RIV) (OTC:CNPOF) announced on Thursday the completion of a previously announced arrangement with RIV Capital ( CNPOF ) whereby FLUENT acquired all of the issued and outstanding Class A common shares of RIV Capital ( CNPOF ) in exchange for FLUENT shares. Under...

BRIEF-Kaken Pharmaceutical Co: To Acquire Aadi Subsidiary Inc For $100 Million

Dec 19, 2024

Dec 20 (Reuters) - Kaken Pharmaceutical Co Ltd ( KKPCF ): * KAKEN PHARMACEUTICAL CO ( KKPCF ) - TO ACQUIRE AADI SUBSIDIARY FOR $100 MILLION Source text: Further company coverage: ...

FedEx to spin off its freight trucking business

Dec 19, 2024

(Reuters) -FedEx announced the much-anticipated spinoff of its freight trucking division on Thursday, as it restructures operations to focus on its core delivery business. Shares jumped 8% in after-hours trading, adding $5 billion to FedEx's market capitalization. Analysts believe the spinoff could unlock up to $20 billion in shareholder value, while clearing the way for FedEx management to zero in...